Brief: Luye Pharma Group Posts FY Net Income Attributable RMB618.7 MLN
31/03/2026 02:40
March 31 (Reuters) - Luye Pharma 2186.HK: LUYE PHARMA GROUP FY NET INCOME ATTRIBUTABLE RMB 618.7 MILLION LUYE PHARMA GROUP FY REVENUE RMB 6,308.4 MILLION Further company coverage: [ ] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Luye Pharma
See all newsBrief: Luye Pharma Proposes Concurrent Repurchase Of US$180 MLN 6.25 Per Cent. Convertible Bonds Due 2028
Brief: Luye Pharma Group Posts FY Net Income Attributable RMB618.7 MLN
Brief: Luye Pharma Says Nanjing Xinan, Ningbo Cinda To Provide Further Capital To Nanjing Luye For RMB285 Mln
Brief: Luye Pharma Receives Commercialization Rights To NHWA For 3 Injectable Antipsychotics In China
Brief: Luye Pharma Says Approval Obtained For LY03017 For Clinical Trials In U.S.